Skip to main content
. 2017 Apr 19;12(4):e0175733. doi: 10.1371/journal.pone.0175733

Fig 3. ELISA identity analysis of trivalent and quadrivalent influenza vaccines using lineage-specific mAbs.

Fig 3

ELISA plates were coated with the indicated purified mAbs at 2 μg/ml and used to capture Reference Antigens B/Brisbane/60/2008 (60 μg/ml) and B/Massachusetts/2/2012 (58 μg/ml), a quadrivalent vaccine containing B/Brisbane and B/Mass antigens at 24 and 40 μg/ml, respectively, a trivalent vaccine containing B/Florida/4/2006 (25 μg/ml), and a trivalent vaccine containing B/Brisbane (27 μg/ml). The starting dilution for all reference antigens and vaccines was 1:300.